ONCS | OncoSec Medical Incorporated

Healthcare sector

• Summary
• Earnings Call
• Events
• Charts
• Historical Data
• Dividends
• Upgrades
• Profile

Category: Biotechnology company

• Industry: Biotechnology

Quick infos

• Headquarters:   California, United States

Trade prices

• Volume:
• Market Cap: 37.84M
• Prev closed: 3.75
• Open: 4.35
• High: 5.27
• Low: 4.08
• 52 week low: 3.52
• 52 week high: 19.6
• Dividends:

Next ER: March 21, 2022 

Top Stories (ONCS)

Company Profile

OncoSec is a late-stage biotechnology company developing immunotherapy cancer treatments using our plasmid DNA delivery platform.

Earnings History

Date	EPS / Forecast	Revenue / Forecast
June 3, 2022
March 18, 2022	-0.25 / -0.18	- / -
December 10, 2021	-0.2452 / -0.2504	- / -
October 22, 2021	-0.3038 / -0.34	- / -
June 4, 2021	-0.25 / -0.2582	- / -
view more

Historical Data

Date		Price		Open	High	Low		Vol	Change	ER
Mar 18, 2022		1.040		1.030	1.050	1.000		79.50K	1.96%
Mar 17, 2022		1.020		1.015	1.050	0.990		59.99K	2.77%
Mar 16, 2022		0.993		0.960	1.030	0.910		105.90K	3.18%
Mar 15, 2022		0.962		0.970	0.983	0.930		46.40K	-0.37%
Mar 14, 2022		0.965		1.040	1.040	0.957		50.66K	-5.34%
Mar 11, 2022		1.020		0.980	1.120	0.915		141.47K	2.52%
Mar 10, 2022		0.995		0.990	1.000	0.962		44.14K	1.52%
Mar 9, 2022		0.980		1.000	1.039	0.978		82.89K	0%
Mar 8, 2022		0.980		0.900	1.030	0.850		124.22K	11.36%
Mar 7, 2022		0.880		0.960	0.960	0.880		66.79K	-8.32%
view more

Show all

NASDAQ - Nasdaq Stock Market

Tweets

News

News for (ONCS)

• OncoSec Releases Presentation Spotlighting the Benefits of the Proposed CGP/Sirtex Transaction and Partnership
  finance.yahoo.com Oct 12, 2020 9:00 am
• OncoSec's Visceral Lesion Applicator (VLA) Electroporation Device Demonstrates Targeted Entry and Deployment in Both Lung and Liver in Data Presented at the Society of Interventional Oncology Annual Meeting
  finance.yahoo.com Oct 12, 2020 8:46 am
• OncoSec Announces Appointment of Sandra Aung, Ph.D. as Senior Vice President, Chief Clinical Development Officer
  finance.yahoo.com Oct 12, 2020 8:30 am
• 
  OncoSec secures new patent in U.S.; shares up 8%
  seekingalpha.com Oct 6, 2020 8:59 pm
• 
  OncoSec Medical prices $15M-share offering
  seekingalpha.com Aug 17, 2020 12:09 pm
• 
  OncoSec Medical intends to offer common stock
  seekingalpha.com Aug 17, 2020 12:20 am
• OncoSec Provides Encouraging Interim Data from Ongoing KEYNOTE-890 Study of TAVO in Combination with KEYTRUDA® for the Treatment of Heavily Pretreated Chemotherapy/Radiotherapy Refractory Metastatic Triple Negative Breast Cancer
  finance.yahoo.com Oct 12, 2020 8:30 am
• OncoSec Sends Letter Urging Shareholders Not to Be Distracted by Alphas Last-Ditch Efforts to Derail CGP/Sirtex Transaction
  finance.yahoo.com Oct 12, 2020 8:30 am
• Data from OncoSec's Visceral Lesion Applicator (VLA) to be Presented at the Society of Interventional Oncology Annual Meeting
  finance.yahoo.com Oct 12, 2020 8:30 am
• OncoSec Announces Issuance of New U.S. Patent Expanding Coverage of TAVO and Its Gene Delivery Platform
  finance.yahoo.com Oct 6, 2020 8:30 am
• Alpha Holdings Proposes $30 Million in Alternate Financing for OncoSec
  finance.yahoo.com Sep 21, 2020 10:03 am
• OncoSec Medical Incorporated Prices $11,000,000 Public Offering
  finance.yahoo.com Sep 21, 2020 8:45 am
• OncoSec Granted Exclusive Worldwide Rights To A Patent Portfolio For The Combination Use Of IL-12 DNA With Checkpoint Inhibitors To Treat Cancer In Several Key Countries
  finance.yahoo.com Sep 21, 2020 8:30 am
• OncoSec Announces $30 Million USD Strategic Investment at a Premium to Market by China Grand Pharmaceutical and Healthcare Holdings (CGP) in Connection with Exclusive License to TAVO in Greater China and 35 Other Asian Countries
  finance.yahoo.com Sep 21, 2020 8:30 am
• Institutional Shareholder Services Inc. ("ISS") Recommends OncoSec Shareholders Vote "FOR" the CGP/Sirtex Transaction
  finance.yahoo.com Sep 21, 2020 8:30 am
• OncoSec to Present at the BTIG Virtual Biotechnology Conference 2020 on Tuesday, August 11, 2020
  finance.yahoo.com Sep 21, 2020 8:30 am
• OncoSec Announces that Nevada Court Denies Alpha Holdings Motion to Enjoin Special Meeting of Shareholders
  finance.yahoo.com Sep 21, 2020 8:00 am
• Why These Stocks Are On The Move
  finance.yahoo.com Sep 21, 2020 2:44 am
• OncoSec Announces Initiation of a Phase 2 Study at the Moffitt Cancer Center to Evaluate the Combination of TAVO plus OPDIVO® as Neoadjuvant Therapy for Melanoma
  finance.yahoo.com Aug 27, 2020 8:30 am
• OncoSec to Present at the LD 500 Virtual Conference on September 2, 2020
  finance.yahoo.com Aug 25, 2020 8:30 am

Talk about OncoSec Medical Incorporated below in comments section below.

Do you think you'll buy? Do you already have active trades now?

EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
This profile is based on publicly available information and is intended to be informative in nature.

Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.

Other ER on Mar 21, 2022 (Same day)